Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: Common types of shorter transcripts are true alternative splice variants

Oncogene

Volumn 17, Issue 21, 1998, Pages 2761-2770

  Wagner, Kay Uwe ^a   Dierisseau, Patricia ^a   Rucker III, Edmund B ^a   Robinson, Gertraud W ^a   Hennighausen, Lothar ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Genomic DNA; Human; Mammary gland; Mice; Pseudogene; TSG101 protein

Indexed keywords

COMPLEMENTARY DNA;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CELL STRAIN 3T3; GENETIC CONSERVATION; HUMAN; MOUSE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; PSEUDOGENE; TRANSACTIVATION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032569885     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202529     Document Type: Article

References (27)

1. Aki T, Yanagisawa S and Akanuma H. (1997). J. Biochem., 122, 271-278.
2. Ali IU, Lidereau R, Theillet C and Callahan R. (1987). Science, 238, 185-188.
3. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
4. Gallahan D and Callahan R. (1997). Oncogene, 14, 1883-1890.
5. Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G and Smith GH. (1996). Cancer Res., 56, 1775-1785.
6. Gayther SA, Barski P, Bailey SJ, Li L, de Foy, KA, Cohen SN, Ponder BA and Caldas C. (1997). Oncogene, 15, 2119-2126.
7. Greenwald I. (1998). Genes Dev., 12, 1751-1762.
8. Hampl M, Hampl J, Plaschke J, Fitze G, Schackert G, Saeger HD and Schackert HK (1998). Biochem. Biophys. Res. Commun., 248, 753-760.
9. Koonin EV and Abagyan RA. (1997). Nat. Genet., 16, 330-331.
10. Kozak M. (1997). EMBO, 16, 2482-2492.
11. Lee MP and Feinberg AP. (1997). Cancer Res., 57, 3131-3134.
12. Li L and Cohen SN. (1996). Cell. 85, 319-329.
13. Li L, Li X, Francke U and Cohen SN. (1997). Cell. 88, 143-154.
14. Li M, Hu J, Heermeier K, Hennighausen L and Furth PA. (1996). Cell Growth Differ., 7, 3-11.
15. Maucuer A, Camonis JH and Sobel A. (1995). Proc. Natl. Acad. Sci. USA, 92, 3100-3104.
16. Ozon S, Maucuer A and Sobel A. (1997). Eur. J. Biochem., 248, 794-806.
17. Ponting CP, Cai YD and Bork P. (1997). J. Mol. Med., 75, 467-469.
18. Reeve AE, Sih SA, Raizis AM and Feinherg AP. (1989). Mol. Cell. Biol., 9, 1799-1803.
19. Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL and Lee DC. (1995). Cancer Res., 55, 3915-3927.
20. Steiner P, Barnes DM, Harris WH and Weinberg RA. (1997). Nat. Genet., 16, 332-333.
21. Sun Z, Pan J, Bubley G and Balk SP. (1997). Oncogene, 15, 3121-3125.
22. Tzeng YJ, Guhl E, Graessmann M and Graessmann A. (1993). Oncogene, 8, 1965-1971.
23. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA and Hennighausen L. (1997). Nucleic. Acids. Res., 25, 4323-4330.
24. Wang Q, Driouch K, Courtois S, Champeme MH, Bieche I, Treilleux I, Briffod M, Rimokh R, Magaud JP, Curmi P, Lidereau R and Puisieux A. (1998). Oncogene, 16, 677-679.
25. Watanabe M, Yanagi Y, Masuhiro Y, Yano T, Yoshikawa H, Yanagisawa J and Kato S. (1998). Biochem. Biophys. Res. Commun., 245, 900-905.
26. Xie W, Li L and Cohen SN. (1998). Proc. Natl. Acad. Sci. USA, 95, 1595-1600.
27. Zhong Q, Chen CF, Chen Y, Chen PL and Lee WH. (1997). Cancer Res., 57, 4225-4228.